Levomepromazine for nausea and vomiting in advanced cancer
Title
Levomepromazine for nausea and vomiting in advanced cancer
Creator
Skinner J; Skinner A
Identifier
Publisher
Hospital Medicine
Date
1999
Subject
Humans; Palliative Care; Non-U.S. Gov't; Research Support; Neoplasms/complications; Dopamine Antagonists/adverse effects/therapeutic use; Methotrimeprazine/adverse effects/therapeutic use; Nausea/drug therapy/etiology; Vomiting/drug therapy/etiology
Description
Levomepromazine (previously known as methotrimeprazine), despite virtually no high quality scientific data to support its use, has become a very popular antiemetic for use in patients with advanced cancer. This article considers the reasons for this.
1999
Rights
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
Journal Article
Citation List Month
Backlog
URL Address
Citation
Skinner J; Skinner A, “Levomepromazine for nausea and vomiting in advanced cancer,” Pediatric Palliative Care Library, accessed April 17, 2024, https://pedpalascnetlibrary.omeka.net/items/show/11793.